|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3183268 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15756525.0 |
| Date of filing the European patent application | 2015-08-19 | |
| (97) | Date of publication of the European application | 2017-06-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-06-10 |
| (86) | Number | PCT/US2015/045898 |
| Date | 2015-08-19 |
| (87) | Number | WO 2016/028896 |
| Date | 2016-02-25 |
| (30) | Number | Date | Country code |
| PCT/CN2014/0846 | 2014-08-19 | WO | |
| PCT/CN2014/0905 | 2014-11-06 | WO |
| (72) |
KENDERIAN, Saad, US
BROGDON, Jennifer, US
GILL, Saar, US
GLASS, David, US
LOEW, Andreas, US
MANNICK, Joan, US
MILONE, Michael, US
MURPHY, Leon, US
PORTER, David L., US
RUELLA, Marco, US
WANG, Yongqiang, CN
WU, Qilong, US
ZHANG, Jiquan, CN
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
The Trustees of The University of Pennsylvania, 3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US |
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Anti-CD123 chimerinis antigeno receptorius (CAR), skirtas naudoti vėžio gydymui |
| ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR (CAR) FOR USE IN CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 11 | 289.00 EUR |
| 2026-08-19 |